Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Pre-procedural Anxiety Counseling in Patients Undergoing Coronary Angiography (PACE-CA)

13 de noviembre de 2026 actualizado por: Armed Forces Institute of Cardiology, Pakistan

Effect of Pre-procedural Counseling on Anxiety in Patients Undergoing Coronary Angiography

The goal of this quasi-experimental study is to assess the effect of preprocedural counselling on the anxiety in patients undergoing coronary angiography. It will include both genders with and without receiving preprocedural counselling. The main question[s] it aims to answer [is/are]:

  • Does pre-procedural counselling effect the anxiety levels among patients undergoing coronary angiography?
  • What is the current level of knowledge of patients regarding coronary angiography procedure?

Researchers will compare Interventional group in which patients will receive the structured counselling before procedure with Control group in which patients will not receive structured counselling to see whether counselling reduces the anxiety or not before procedure.

Participants will be asked to provide the following details;

  • Demographic questionnaire: Provide information regarding age, gender, marital status, educational level, and occupation.
  • Knowledge questionnaire: Complete a 20-item questionnaire assessing knowledge about the angiography procedure.
  • Anxiety assessment: Complete the 20-item Spielberger State Anxiety Inventory (STAI) to assess situational anxiety approximately 30 minutes before the procedure on the day of admission.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

Detailed Description

Coronary artery disease (CAD) is a major contributor to cardiovascular morbidity and mortality worldwide. Coronary angiography is an important diagnostic procedure used to evaluate coronary artery disease. However, uncertainty regarding the procedure, concerns about potential complications, and inadequate understanding of the procedural process may contribute to psychological distress before catheterization. Preprocedural anxiety may be accompanied by sympathetic nervous system activation, increased catecholamine release, elevated myocardial oxygen demand, and changes in physiological parameters. In some patients, anxiety may also contribute to procedural difficulties, including radial artery spasm.

Providing clear, structured information before coronary angiography may help patients develop realistic expectations, improve their understanding of the procedure, and cope more effectively with procedural anxiety. Nurse-led education is a non-pharmacological approach that can be incorporated into routine cardiac catheterization services. This study will evaluate this approach in the clinical setting of the Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD), Rawalpindi, Pakistan.

Counselling Procedure

The educational intervention will be delivered individually by a cardiac catheterization nurse in a private room. The session will combine verbal explanations with a written information brochure to provide consistent information about the patient's preparation, the procedure itself, and recovery.

The educational content will include the following components:

  1. Preparation before the procedure

    Participants will receive explanations about the purpose of coronary angiography and the preparations required before catheterization. These will include fasting requirements, medication instructions as advised by the treating team, routine investigations, personal hygiene, and hospital gowning. The importance of following the clinical team's instructions will be emphasized.

  2. Information about the procedure

    The nurse will explain the main steps involved in coronary angiography, including the use of local anaesthesia, insertion of a catheter through the radial artery at the wrist or the femoral artery in the groin, and administration of contrast dye to visualize the coronary arteries. Participants will be informed that they generally remain awake during the procedure and may experience sensations such as warmth following contrast administration. The explanation will be intended to familiarize patients with the procedure and reduce uncertainty about what to expect.

  3. Care following the procedure

Counselling will cover postprocedural monitoring and recovery, including care of the arterial access site, movement restrictions when indicated, recommended fluid intake according to the clinical team's instructions, and avoidance of strenuous physical activity for the period advised by the treating team. General home-care and lifestyle guidance relevant to recovery will also be provided.

Assessment Procedures

Assessments will be conducted using standardized procedures in both study groups. The researcher-developed knowledge questionnaire will be used to assess patients' understanding of coronary angiography. Physiological measurements will be obtained using the same assessment procedures at the designated assessment points. State anxiety will be evaluated using the State scale of the State-Trait Anxiety Inventory (STAI-S).

The intervention group will undergo assessment before counselling and subsequent reassessment before catheterization. The control group will undergo corresponding assessments while receiving routine preprocedural care.

Grouping and Data Collection

The study will use individual matching to improve comparability between the intervention and control groups. Matching will be based on age, gender, and educational level. Participants will receive care according to their assigned study group, and information will be collected using the same assessment instruments and procedures across both groups.

The collected data will be used to examine differences in anxiety, patient knowledge, and physiological parameters between the groups. The findings may help inform the development of practical, nurse-led educational approaches for patients preparing to undergo coronary angiography.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

80

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Dr Javeria Kamran Dy Dir R&D dept, MBBS, MsPH
  • Número de teléfono: 92 51 9272654 92 3215502381
  • Correo electrónico: javeriakamran@afic.gov.pk

Ubicaciones de estudio

    • Punjab Province
      • Rawalpindi, Punjab Province, Pakistán, 44000
        • Armed Institute of Cardiology,AFIC
        • Contacto:
        • Investigador principal:
          • Hamda Tayyab, BS in nursing

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

25 años a 65 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • Planned for elective cardiac catheterization
  • Cognition intact/mentally alert

Exclusion Criteria:

  • Cardiopulmonary resuscitation before admission
  • Inability to provide written informed consent
  • Previous cardiac catheterization
  • Planned for primary PCI
  • Previously involved in cardiac rehabilitation program
  • Patients with history of antipsychotic drugs
  • Patients undergoing electrophysiological procedures

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Prevención
  • Asignación: No aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Nurse-Led Pre-Procedural Educational Intervention

Participants will receive a 20-30-minute structured counseling session by a specialized nurse, including a written brochure and explanations about the procedure, post-procedure care, and home care.

Participants will receive a 20-30-minute individual educational counseling session delivered by a specialized cardiac catheterization nurse in a separate room. Knowledge will be assessed before counseling. The session will include written informational materials/brochures and explanations regarding the cardiac catheterization procedure, post-procedural care, and home care. Heart rate, systolic and diastolic blood pressure, respiratory rate, and anxiety levels using the STAI-S scale will be recorded at baseline and reassessed before catheterization. Post-counseling anxiety will be assessed by an independent research assistant blinded to group allocation.

Sin intervención: Control Group: Patients receive routine pre-procedural care

Participants will attend a 10-15-minute session with a specialized cardiac catheterization nurse without structured educational counseling. Knowledge, physiological parameters, and anxiety levels will be assessed at baseline and reassessed before catheterization.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in State-Trait Anxiety Inventory-State (STAI-S)
Periodo de tiempo: At baseline score before counseling on the day the procedure is planned , and again on the day of coronary angiography before the procedure.

Change in anxiety levels measured using the State-Trait Anxiety Inventory-State (STAI-S) scale between baseline assessment before counseling and reassessment before coronary angiography. Scores will be compared between the intervention and control groups

At baseline score before counseling on the day the procedure is planned , and again on the day of coronary angiography before the procedure.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Knowledge Score
Periodo de tiempo: Baseline on the day the procedure is planned before Coronary Angiography

Knowledge scores assessed using the researcher-developed knowledge questionnaire and expressed as percentages, compared between the intervention and control groups.

Baseline on the day the procedure is planned before Coronary Angiography
Change in Heart Rate
Periodo de tiempo: Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure.

Change in heart rate measured in beats per minute (bpm) between baseline assessment and reassessment before coronary angiography.

Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure.
Change in Systolic Blood Pressure
Periodo de tiempo: Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure.

Systolic blood pressure will be measured in millimetres of mercury (mmHg)

Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure.
Change in Diastolic Blood Pressure
Periodo de tiempo: Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure

Diastolic Blood Pressure will be measured in millimetres of mercury (mmHg)

Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure
Change in Respiratory Rate
Periodo de tiempo: Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure

Respiratory rate will be measured in breaths per minute

Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Investigadores

  • Investigador principal: Hamda Tayyab, BS in nursing, AFIC/NIHD

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

15 de noviembre de 2026

Finalización primaria (Estimado)

15 de mayo de 2027

Finalización del estudio (Estimado)

15 de mayo de 2027

Fechas de registro del estudio

Enviado por primera vez

2 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Publicado por primera vez (Actual)

17 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • 9/2/R&D/2025/392

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

Individual participant data will not be shared with other researchers under the current study plan. Study findings may be disseminated through scientific publications in aggregate form, while maintaining participant confidentiality.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .